{"id":70664,"date":"2026-05-12T08:56:17","date_gmt":"2026-05-12T08:56:17","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70664"},"modified":"2026-05-21T07:14:10","modified_gmt":"2026-05-21T07:14:10","slug":"mots-c","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/mots-c\/","title":{"rendered":"MOTS-c"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je MOTS-c?<\/h3>\n<p style=\"margin: 0;\"><strong>MOTS-c<\/strong> (Mitochondri\u00e1ln\u011b k\u00f3dovan\u00fd sign\u00e1ln\u00ed peptid z otev\u0159en\u00e9ho \u010dtec\u00edho r\u00e1mce 12S rRNA) je 16-aminokyselinov\u00fd peptid identifikovan\u00fd v roce 2015. Podle publikovan\u00fdch preklinick\u00fdch studi\u00ed p\u016fsob\u00ed jako imit\u00e1tor cvi\u010den\u00ed a metabolick\u00fd regul\u00e1tor aktivac\u00ed AMPK dr\u00e1hy, obnoven\u00edm citlivosti na inzul\u00edn a modulac\u00ed exprese gen\u016f v reakci na mitochondri\u00e1ln\u00ed stres. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch vial\u00e1ch o obsahu 10 mg a\u017e 40 mg v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1627580-64-6<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>100<\/sub>H<sub>152<\/sub>N<sub>28<\/sub>O<sub>22<\/sub>S<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">2174.62 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR, 16 aminokyselin; k\u00f3dov\u00e1no v mitochondri\u00e1ln\u00edm genu 12S rRNA)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (b\u00edl\u00fd a\u017e sv\u011btle \u017elut\u00fd)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00e9: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00e9: 2\u20138 \u00b0C, pou\u017eijte do ~30 dn\u016f. Chra\u0148te p\u0159ed sv\u011btlem. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Co je MOTS-c?<\/h2>\n<p><strong>MOTS-c<\/strong> (Mitochondri\u00e1ln\u011b k\u00f3dovan\u00fd peptid z otev\u0159en\u00e9ho \u010dtec\u00edho r\u00e1mce 12S rRNA) je 16-aminokyselinov\u00fd peptid poprv\u00e9 identifikovan\u00fd Lee et al. v <em>Cell Metabolism<\/em> (2015) jako z\u00e1stupce nov\u011b rozpoznan\u00e9 t\u0159\u00eddy mitochondri\u00e1ln\u011b odvozen\u00fdch peptid\u016f (MDPs). Na rozd\u00edl od v\u0161ech ostatn\u00edch peptid\u016f v katalogu v\u00fdzkumn\u00fdch l\u00e1tek \u2014 kter\u00e9 jsou k\u00f3dov\u00e1ny jadernou DNA a syntetizov\u00e1ny v cytoplazm\u011b \u2014 je MOTS-c k\u00f3dov\u00e1n v mitochondri\u00e1ln\u00edm genu 12S rRNA a translatov\u00e1n mitochondri\u00e1ln\u00edmi ribozomy. Tento neobvykl\u00fd biologick\u00fd p\u016fvod z n\u011bj \u010din\u00ed p\u0159\u00edm\u00fd intracelul\u00e1rn\u00ed sign\u00e1l stavu mitochondri\u00ed a nej\u010dast\u011bji citovan\u00e9ho z\u00e1stupce t\u0159\u00eddy peptid\u016f, kter\u00e1 zahrnuje humanin a rodinu SHLP peptid\u016f.<\/p>\n<p>Peptidov\u00e1 sekvence je MRWQEMGYIFYPRKLR, molekulov\u00e1 hmotnost p\u0159ibli\u017en\u011b 2 175 Da, empirick\u00fd vzorec C<sub>100<\/sub>H<sub>152<\/sub>N<sub>28<\/sub>O<sub>22<\/sub>S<sub>2<\/sub>. Endogenn\u00ed MOTS-c se p\u0159i metabolick\u00e9m a oxida\u010dn\u00edm stresu p\u0159esouv\u00e1 z mitochondri\u00ed do j\u00e1dra, kde reguluje genov\u00fd program fol\u00e1tov\u00e9ho cyklu a metabolismu methioninu \u2014 mechanismus, kter\u00fd nem\u00e1 obdoby mezi jadern\u011b k\u00f3dovan\u00fdmi peptidy. MOTS-c je dod\u00e1v\u00e1n jako vysoce \u010dist\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek pro rekonstituci s bakteriostatickou vodou a je <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong>. Nen\u00ed schv\u00e1len FDA, EMA ani MHRA pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at. Pro souvisej\u00edc\u00ed metabolick\u00e9 a dlouhov\u011bkostn\u00ed peptidy viz na\u0161e pln\u00e9 <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a>.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 AMPK, metabolismus gluk\u00f3zy a nukle\u00e1rn\u00ed translokace<\/h2>\n<p>Co odli\u0161uje MOTS-c od star\u0161\u00edch metabolick\u00fdch peptid\u016f, je jeho <strong>t\u0159\u00edmod\u00e1ln\u00ed mechanismus \u00fa\u010dinku<\/strong> kter\u00fd zahrnuje mitochondrie, cytoplazmu a j\u00e1dro \u2014 ka\u017ed\u00fd z nich p\u0159isp\u00edv\u00e1 k pozorovan\u00e9mu metabolick\u00e9mu fenotypu v publikovan\u00e9m v\u00fdzkumu:<\/p>\n<ul>\n<li><strong>Aktivace dr\u00e1hy AMPK<\/strong> \u2014 MOTS-c aktivuje AMP-aktivovanou proteinkin\u00e1zu (AMPK), hlavn\u00ed bun\u011b\u010dn\u00fd senzor energie, zv\u00fd\u0161en\u00edm intracelul\u00e1rn\u00edho pom\u011bru AMP:ATP a prost\u0159ednictv\u00edm mechanismu z\u00e1visl\u00e9ho na fol\u00e1tov\u00e9m cyklu. Aktivace AMPK posouv\u00e1 bun\u011b\u010dn\u00fd metabolismus sm\u011brem ke katabolismu: zv\u00fd\u0161en\u00fd p\u0159\u00edjem gluk\u00f3zy p\u0159es translokaci GLUT4, oxidace mastn\u00fdch kyselin, mitochondri\u00e1ln\u00ed biogeneze prost\u0159ednictv\u00edm PGC-1\u03b1 a autofagie. Toto je stejn\u00e1 dr\u00e1ha, na kterou c\u00edl\u00ed metformin a cvi\u010den\u00ed, co\u017e MOTS-c v publikovan\u00e9 literatu\u0159e vyneslo ozna\u010den\u00ed \u201cpeptid napodobuj\u00edc\u00ed cvi\u010den\u00ed\u201d.<\/li>\n<li><strong>Citlivost na inzul\u00edn a vyu\u017eit\u00ed gluk\u00f3zy<\/strong> \u2014 V modelech hlodavc\u016f s vysokotu\u010dnou dietou pod\u00e1v\u00e1n\u00ed MOTS-c obnovuje inzulinem stimulovan\u00fd p\u0159\u00edjem gluk\u00f3zy ve skelet\u00e1ln\u00edm svalu a tukov\u00e9 tk\u00e1ni. V n\u011bkter\u00fdch v\u00fdzkumn\u00fdch modelech je \u00fa\u010dinek nez\u00e1visl\u00fd na zm\u011bn\u011b t\u011blesn\u00e9 hmotnosti, co\u017e nazna\u010duje p\u0159\u00edm\u00fd mechanismus zvy\u0161ov\u00e1n\u00ed citlivosti na inzul\u00edn sp\u00ed\u0161e ne\u017e sekund\u00e1rn\u00ed \u00fa\u010dinek \u00fabytku hmotnosti. Ob\u00e9zn\u00ed my\u0161i l\u00e9\u010den\u00e9 MOTS-c vykazuj\u00ed normalizovanou or\u00e1ln\u00ed gluk\u00f3zovou toleranci a zlep\u0161en\u00e9 parametry euglykemick\u00e9ho svorkov\u00e9ho testu v publikovan\u00e9m v\u00fdzkumu.<\/li>\n<li><strong>Nukle\u00e1rn\u00ed translokace a adaptivn\u00ed genov\u00e1 exprese<\/strong> \u2014 P\u0159i metabolick\u00e9m nebo oxida\u010dn\u00edm stresu se MOTS-c p\u0159esouv\u00e1 z mitochondri\u00ed do j\u00e1dra, kde spolureguluje transkrip\u010dn\u00ed program zam\u011b\u0159en\u00fd na antioxida\u010dn\u00ed odpov\u011b\u010f (NRF2), fol\u00e1t-methioninov\u00fd cyklus a adaptivn\u00ed metabolick\u00e9 geny. Tato retrogr\u00e1dn\u00ed signalizace z mitochondri\u00ed do j\u00e1dra je jedn\u00edm z prvn\u00edch p\u0159\u00edklad\u016f mezibun\u011b\u010dn\u00e9 komunikace na \u00farovni peptid\u016f a je z\u00e1kladem \u0161ir\u0161\u00edch \u00fa\u010dink\u016f MOTS-c mimo p\u0159\u00edmou aktivaci AMPK.<\/li>\n<\/ul>\n<p>Biologick\u00e1 p\u0159ita\u017elivost MOTS-c v metabolick\u00e9m v\u00fdzkumu spo\u010d\u00edv\u00e1 v konvergenci t\u011bchto t\u0159\u00ed mechanism\u016f na dr\u00e1hy, o kter\u00fdch je ji\u017e zn\u00e1mo, \u017ee zprost\u0159edkov\u00e1vaj\u00ed v\u00fdhody cvi\u010den\u00ed a kalorick\u00e9 restrikce. Proto\u017ee endogenn\u00ed MOTS-c s v\u011bkem v\u00fdrazn\u011b kles\u00e1 v lidsk\u00e9m s\u00e9ru (~50% redukce b\u011bhem dosp\u011bl\u00e9ho \u017eivota v publikovan\u00fdch kohort\u00e1ch), stal se tento peptid \u010dast\u00fdm c\u00edlem ve v\u00fdzkumu st\u00e1rnut\u00ed a dlouhov\u011bkosti i v souvislosti s metabolick\u00fdm syndromem.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>MOTS-c se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu, kter\u00fd zkoum\u00e1:<\/p>\n<ul>\n<li><strong>Metabolick\u00fd syndrom a v\u00fdzkum obezity<\/strong> \u2014 citlivost na inzul\u00edn, gluk\u00f3zov\u00e1 tolerance, t\u011blesn\u00e9 slo\u017een\u00ed u model\u016f hlodavc\u016f s vysokotu\u010dnou dietou; referen\u010dn\u00ed peptid pro v\u00fdzkum intervence AMPK (Lee et al., Cell Metabolism 2015; Reynolds et al., Front Physiol 2021)<\/li>\n<li><strong>Modely predklinick\u00e9ho diabetu typu 2<\/strong> \u2014 modely db\/db, ZDF a streptozotocinem indukovan\u00fdm diabetem; \u00fa\u010dinky na hepat\u00e1ln\u00ed citlivost na inzul\u00edn, funkci beta-bun\u011bk a n\u00e1hradn\u00ed markery HbA1c<\/li>\n<li><strong>V\u00fdzkum kapacity cvi\u010den\u00ed a mitochondri\u00e1ln\u00ed biogeneze<\/strong> \u2014 n\u00e1hradn\u00ed markery pro vytrvalost na b\u011b\u017eeck\u00e9m p\u00e1se, VO2max, kopie mitochondri\u00e1ln\u00ed DNA, exprese PGC-1\u03b1 ve v\u00fdzkumu kostern\u00edho svalu<sub>2<\/sub>maxim\u00e1ln\u00ed n\u00e1hradn\u00ed ukazatele, exprese PGC-1\u03b1, po\u010det kopi\u00ed mitochondri\u00e1ln\u00ed DNA ve v\u00fdzkumu kostern\u00edho svalstva<\/li>\n<li><strong>\u2014 modely prodlou\u017een\u00ed \u017eivota, exprese MOTS-c v s\u00e9ru kles\u00e1 s v\u011bkem, co\u017e z n\u011bj \u010din\u00ed kandid\u00e1ta na n\u00e1hradu peptidu ve v\u00fdzkumu geroscience<\/strong> \u2014 modely prodlou\u017een\u00ed d\u00e9lky \u017eivota, inzulinov\u00e1 rezistence souvisej\u00edc\u00ed s v\u011bkem, sarkopenie; hladiny MOTS-c v s\u00e9ru s v\u011bkem klesaj\u00ed, co\u017e z n\u011bj \u010din\u00ed kandid\u00e1tn\u00ed n\u00e1hradn\u00ed peptid ve v\u00fdzkumu gerov\u011bdy.<\/li>\n<li><strong>Kardiovaskul\u00e1rn\u00ed a ren\u00e1ln\u00ed ochrana<\/strong> \u2014 ischemicko-reperfuzn\u00ed po\u0161kozen\u00ed, markery oxida\u010dn\u00edho stresu, mitochondri\u00e1ln\u00ed dysfunkce ve v\u00fdzkumn\u00fdch modelech srde\u010dn\u00ed a ren\u00e1ln\u00ed tk\u00e1n\u011b<\/li>\n<li><strong>V\u00fdzkum zdrav\u00ed kost\u00ed<\/strong> \u2014 diferenciace osteoblast\u016f, hustota kostn\u00edch miner\u00e1l\u016f, modely v\u011bkem podm\u00edn\u011bn\u00e9 osteopor\u00f3zy<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum mitochondri\u00e1ln\u00edch peptid\u016f<\/strong> \u2014 srovn\u00e1n\u00ed s dal\u0161\u00edmi mitochondri\u00e1ln\u011b c\u00edlen\u00fdmi peptidy, jako je <a href=\"https:\/\/medsbase.com\/cs\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a>. Pro metodologick\u00e9 srovn\u00e1n\u00ed viz n\u00ed\u017ee uvedenou sekci.<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext, kam MOTS-c zapad\u00e1 v r\u00e1mci metabolick\u00e9 a dlouhov\u011bkostn\u00ed peptidov\u00e9 krajiny, viz <a href=\"https:\/\/medsbase.com\/cs\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> jako kanonick\u00fd mitochondri\u00e1ln\u00ed peptid c\u00edlen\u00fd na kardiolipin, <a href=\"https:\/\/medsbase.com\/cs\/epitalon\/\">Epitalon<\/a> pro v\u00fdzkum telomer\/dlouhov\u011bkosti a <a href=\"https:\/\/medsbase.com\/cs\/nad\/\">NAD+<\/a> pro v\u00fdzkum metabolick\u00e9 osy NAD. Proch\u00e1zejte cel\u00fd <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a> pro p\u0159\u00edbuzn\u00e9 slou\u010deniny.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase nab\u00edz\u00ed MOTS-c ve t\u0159ech velikostech lyofilizovan\u00fdch vialek kalibrovan\u00fdch na typick\u00e9 d\u00e9lky v\u00fdzkumn\u00fdch protokol\u016f. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00ed po 10 nebo 20 vialk\u00e1ch s \u00fapln\u00fdmi pokyny pro rekonstituci:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00fd v\u00fdzkumn\u00fd p\u0159\u00edpad u\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 s\u00edla, protokoly s kr\u00e1tk\u00fdm cyklem<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">St\u0159edn\u011b velk\u00e1 viale pro hromadn\u00e9 pou\u017eit\u00ed, sn\u00ed\u017een\u00fd objem rekonstituce na d\u00e1vku<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>40 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protokoly s prodlou\u017een\u00fdm cyklem, v\u00fdzkum dlouhov\u011bkosti, nejni\u017e\u0161\u00ed cena za mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>V\u0161echny t\u0159i s\u00edly jsou stejn\u00e9 chemick\u00e9 formy (lyofilizovan\u00fd pr\u00e1\u0161ek, \u010distota 99 %+ HPLC). V\u011bt\u0161\u00ed vialky poskytuj\u00ed v\u011bt\u0161\u00ed flexibilitu d\u00e1vkov\u00e1n\u00ed na viale a ni\u017e\u0161\u00ed cenu za mg; nev\u00fdhodou je, \u017ee rekonstituovan\u00fd roztok mus\u00ed b\u00fdt pou\u017eit do 30 dn\u016f, tak\u017ee v\u00edcem\u011bs\u00ed\u010dn\u00ed protokoly t\u011b\u017e\u00ed z v\u011bt\u0161\u00edch vialek pouze tehdy, kdy\u017e je odpov\u00eddaj\u00edc\u00ed t\u00fddenn\u00ed v\u00fdzkumn\u00e1 d\u00e1vka vysok\u00e1.<\/p>\n<h2>Srovn\u00e1n\u00ed \u2014 MOTS-c vs SS-31 (Elamipretide)<\/h2>\n<p>MOTS-c a <a href=\"https:\/\/medsbase.com\/cs\/ss-31-elamipretide\/\">SS-31<\/a> jsou dva nej\u010dast\u011bji citovan\u00e9 mitochondri\u00e1ln\u011b c\u00edlen\u00e9 peptidy v sou\u010dasn\u00e9m v\u00fdzkumu. Jsou mechanisticky odli\u0161n\u00e9 a komplement\u00e1rn\u00ed, nikoli redundantn\u00ed: MOTS-c je sign\u00e1ln\u00ed peptid, kter\u00fd aktivuje AMPK a jadern\u011b k\u00f3dovan\u00e9 adaptivn\u00ed programy, zat\u00edmco SS-31 je strukturn\u00ed peptid, kter\u00fd v\u00e1\u017ee kardiolipin ve vnit\u0159n\u00ed mitochondri\u00e1ln\u00ed membr\u00e1n\u011b a stabilizuje elektronov\u00fd transportn\u00ed \u0159et\u011bzec. V\u00fdzkumn\u00edci je proto \u010dasto kombinuj\u00ed v modelech mitochondri\u00e1ln\u00ed dysfunkce.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">MOTS-c<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9lka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">16 aminokyselin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 aminokyseliny (tetrapeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>P\u016fvod<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">K\u00f3dov\u00e1n mitochondri\u00e1ln\u00ed DNA (gen 12S rRNA)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Syntetick\u00fd Szeto-Schiller\u016fv peptid<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e1rn\u00ed mechanismus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aktivace AMPK, exprese jadern\u00fdch gen\u016f<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Vazba na kardiolipin, stabilizace ETC<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Bun\u011b\u010dn\u00fd c\u00edl<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mitochondrie \u2192 cytoplazma \u2192 j\u00e1dro<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pouze vnit\u0159n\u00ed mitochondri\u00e1ln\u00ed membr\u00e1na<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201315 mg, 1\u20133\u00d7 t\u00fddn\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20135 mg, denn\u011b<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Nejsiln\u011bj\u0161\u00ed v\u00fdzkumn\u00fd sign\u00e1l<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Citlivost na inzul\u00edn, v\u00fdkonnost p\u0159i cvi\u010den\u00ed, st\u00e1rnut\u00ed<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Srde\u010dn\u00ed ischemie, ren\u00e1ln\u00ed mitochondri\u00e1ln\u00ed dysfunkce<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Kombinov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u010casto pod\u00e1v\u00e1no spole\u010dn\u011b se SS-31 ve v\u00fdzkumu mitochondri\u00ed<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u010casto pod\u00e1v\u00e1no spole\u010dn\u011b s MOTS-c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Tyto dva peptidy p\u016fsob\u00ed na r\u016fzn\u00fdch \u00farovn\u00edch mitochondri\u00e1ln\u00ed biologie \u2014 MOTS-c reguluje metabolickou transkripci, SS-31 stabilizuje membr\u00e1novou architekturu \u2014 a proto \u0159e\u0161\u00ed neprot\u00ednaj\u00edc\u00ed se v\u00fdzkumn\u00e9 ot\u00e1zky. Pro v\u00fdzkum metabolismu\/inzulinov\u00e9 senzitivity je MOTS-c v\u00fdchoz\u00ed volbou. Pro kardi\u00e1ln\u00ed, ren\u00e1ln\u00ed nebo ischemicko-reperfuzn\u00ed ochranu mitochondri\u00ed je SS-31 standardn\u00edm kompar\u00e1torem.<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> Lyofilizovan\u00e9 lahvi\u010dky skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu pro kr\u00e1tkodob\u00e9 pracovn\u00ed z\u00e1soby. Pro dlouhodob\u00e9 skladov\u00e1n\u00ed v neotev\u0159en\u00e9m stavu zmrazte p\u0159i \u221220 \u00b0C. Lyofilizovan\u00fd MOTS-c je stabiln\u00ed v chladni\u010dce a\u017e 24 m\u011bs\u00edc\u016f a p\u0159i \u221220 \u00b0C a\u017e 36 m\u011bs\u00edc\u016f. Vyvarujte se cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed lyofilizovan\u00e9ho pr\u00e1\u0161ku.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> injektujte bakteriostatickou vodu po bo\u010dn\u00ed st\u011bn\u011b lahvi\u010dky s peptidem (ne p\u0159\u00edmo na lyofilizovan\u00fd kol\u00e1\u010d). Pro lahvi\u010dku 10 mg odpov\u00edd\u00e1 2,0 ml bakteriostatick\u00e9 vody pracovn\u00ed koncentraci 5 mg\/ml \u2013 10 d\u00edlc\u016f na inzul\u00ednov\u00e9 st\u0159\u00edka\u010dce U-100 odpov\u00edd\u00e1 500 mcg. Jemn\u011b zakru\u017ete \u2013 <strong>ne<\/strong> net\u0159epejte \u2013 a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok by m\u011bl b\u00fdt \u010dir\u00fd a bezbarv\u00fd.<\/p>\n<p><strong>Po rekonstituci:<\/strong> Skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C a pou\u017eijte do 30 dn\u016f pro optim\u00e1ln\u00ed stabilitu. Rozpu\u0161t\u011bn\u00fd roztok nezmrazujte \u2014 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed degraduj\u00ed integritu peptidu. Zlikvidujte jak\u00e9koli lahvi\u010dky se z\u00e1kalem, sra\u017eeninami nebo zm\u011bnou barvy. Proto\u017ee se MOTS-c ve v\u00fdzkumn\u00fdch protokolech obvykle pod\u00e1v\u00e1 1\u20133kr\u00e1t t\u00fddn\u011b, jedna rozpu\u0161t\u011bn\u00e1 lahvi\u010dka o obsahu 10 mg obvykle posta\u010duje na 2\u20133 t\u00fddny pod\u00e1v\u00e1n\u00ed v z\u00e1vislosti na c\u00edlov\u00e9 d\u00e1vce a frekvenci.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se MOTS-c pou\u017e\u00edv\u00e1 ve v\u00fdzkumu?<\/h3>\n<p>MOTS-c se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zam\u011b\u0159en\u00e9m na inzulinovou senzitivitu, modely diabetu 2. typu, fyzickou v\u00fdkonnost, mitochondri\u00e1ln\u00ed biogenezi, st\u00e1rnut\u00ed a dlouhov\u011bkost, kardiovaskul\u00e1rn\u00ed ischemicko-reperfuzn\u00ed po\u0161kozen\u00ed, ren\u00e1ln\u00ed mitochondri\u00e1ln\u00ed dysfunkci a zdrav\u00ed kost\u00ed. Jde o nej\u010dast\u011bji citovan\u00fd mitochondri\u00e1ln\u011b k\u00f3dovan\u00fd sign\u00e1ln\u00ed peptid v odborn\u00e9 literatu\u0159e a slou\u017e\u00ed jako referen\u010dn\u00ed bod pro z\u00e1sahy do AMPK osy. MOTS-c je <strong>ne<\/strong> schv\u00e1len FDA a je zde dod\u00e1v\u00e1n v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<h3>Jak se MOTS-c li\u0161\u00ed od SS-31 (Elamipretidu)?<\/h3>\n<p>MOTS-c je 16-aminokyselinov\u00fd sign\u00e1ln\u00ed peptid k\u00f3dovan\u00fd mitochondri\u00e1ln\u00ed DNA, kter\u00fd aktivuje AMPK a reguluje expresi gen\u016f v j\u00e1d\u0159e. SS-31 je 4-aminokyselinov\u00fd syntetick\u00fd Szeto-Schiller\u016fv peptid, kter\u00fd v\u00e1\u017ee kardiolipin ve vnit\u0159n\u00ed mitochondri\u00e1ln\u00ed membr\u00e1n\u011b a stabilizuje elektronov\u00fd transportn\u00ed \u0159et\u011bzec. Tyto dva peptidy p\u016fsob\u00ed na r\u016fzn\u00fdch \u00farovn\u00edch mitochondri\u00e1ln\u00ed biologie \u2014 MOTS-c na \u00farovni metabolick\u00e9 transkripce, SS-31 na \u00farovni membr\u00e1nov\u00e9 architektury \u2014 a \u010dasto se spole\u010dn\u011b pod\u00e1vaj\u00ed ve v\u00fdzkumu mitochondri\u00e1ln\u00ed dysfunkce.<\/p>\n<h3>Jak\u00e1 je typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka MOTS-c?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly obvykle pou\u017e\u00edvaj\u00ed 5\u201315 mg na pod\u00e1n\u00ed u hlodavc\u016f, pod\u00e1van\u00e9 1\u20133kr\u00e1t t\u00fddn\u011b v cyklech trvaj\u00edc\u00edch 4\u201312 t\u00fddn\u016f. 10mg lahvi\u010dka rekonstituovan\u00e1 s 2,0 ml bakteriostatick\u00e9 vody poskytne koncentraci 5 mg\/ml \u2014 10 d\u00edlek na U-100 st\u0159\u00edka\u010dce odpov\u00edd\u00e1 500 mcg.<\/p>\n<h3>Je MOTS-c schv\u00e1len FDA?<\/h3>\n<p>Ne. MOTS-c nen\u00ed schv\u00e1len FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. Ve\u0161ker\u00fd MOTS-c prod\u00e1van\u00fd dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010den pro laboratorn\u00ed v\u00fdzkum a nem\u011bl by b\u00fdt pod\u00e1v\u00e1n lidem nebo zv\u00ed\u0159at\u016fm.<\/p>\n<h3>Jak by m\u011bl b\u00fdt MOTS-c skladov\u00e1n?<\/h3>\n<p>Lyofilizovan\u00e9 lahvi\u010dky: kr\u00e1tkodob\u011b skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, dlouhodob\u011b neotev\u0159en\u00e9 lahvi\u010dky p\u0159i \u221220 \u00b0C. Rekonstituovan\u00fd roztok: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, pou\u017eijte do 30 dn\u016f. Rekonstituovan\u00fd roztok nezmrazujte \u2014 mrazic\u00ed cykly degraduj\u00ed peptid. V\u017edy chra\u0148te p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem.<\/p>\n<h3>Jak rekonstituovat MOTS-c?<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho rekonstitu\u010dn\u00edho postupu. P\u0159idejte bakteriostatickou vodu po st\u011bn\u011b lahvi\u010dky (ne p\u0159\u00edmo na lyofilizovan\u00fd pr\u00e1\u0161ek), jemn\u011b prot\u0159epejte a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Ne <strong>ne<\/strong> prot\u0159ep\u00e1vejte lahvi\u010dku. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok je \u010dir\u00fd a bezbarv\u00fd. Pro lahvi\u010dku 10 mg + 2,0 ml rozpou\u0161t\u011bdla je pracovn\u00ed koncentrace 5 mg\/ml.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed MOTS-c v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch o s\u00edle 10 mg, 20 mg a 40 mg. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00ed po 10 nebo 20 lahvi\u010dk\u00e1ch. V\u0161echny lahvi\u010dky maj\u00ed HPLC \u010distotu 99 %+ a certifik\u00e1t o anal\u00fdze je k dispozici na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Pro\u010d se MOTS-c naz\u00fdv\u00e1 \u201cpeptid napodobuj\u00edc\u00ed cvi\u010den\u00ed\u201d?<\/h3>\n<p>Term\u00edn vych\u00e1z\u00ed z toho, \u017ee MOTS-c aktivuje AMPK a m\u00e1 n\u00e1sledn\u00e9 \u00fa\u010dinky na p\u0159\u00edjem gluk\u00f3zy, oxidaci mastn\u00fdch kyselin a biogenezi mitochondri\u00ed \u2014 stejnou intracelul\u00e1rn\u00ed dr\u00e1hu, kter\u00e1 je zodpov\u011bdn\u00e1 za mnoh\u00e9 metabolick\u00e9 adaptace na cvi\u010den\u00ed. Ve publikovan\u00e9m v\u00fdzkumu pod\u00e1v\u00e1n\u00ed MOTS-c replikuje n\u011bkolik fenotyp\u016f tr\u00e9ninku u sedav\u00fdch zv\u00ed\u0159at: zlep\u0161enou citlivost na inzul\u00edn, zv\u00fd\u0161enou vytrvalost na b\u011bhac\u00edm p\u00e1su a zv\u00fd\u0161enou expresi PGC-1\u03b1 ve svalov\u00e9 tk\u00e1ni. Tato metafora je \u0161iroce pou\u017e\u00edv\u00e1na v gerontologick\u00e9m v\u00fdzkumu a literatu\u0159e o metabolick\u00e9m syndromu.<\/p>\n<h3>Lze MOTS-c a SS-31 kombinovat ve v\u00fdzkumu?<\/h3>\n<p>Ano. MOTS-c a SS-31 p\u016fsob\u00ed na r\u016fzn\u00e9 \u00farovn\u011b mitochondri\u00e1ln\u00ed biologie a \u010dasto jsou spole\u010dn\u011b pod\u00e1v\u00e1ny v preklinick\u00e9m v\u00fdzkumu mitochondri\u00e1ln\u00ed dysfunkce. MOTS-c reguluje metabolickou transkripci prost\u0159ednictv\u00edm AMPK; SS-31 stabilizuje lipidov\u00e9 prost\u0159ed\u00ed vnit\u0159n\u00ed membr\u00e1ny. Jejich mechanismy jsou komplement\u00e1rn\u00ed sp\u00ed\u0161e ne\u017e p\u0159ekr\u00fdvaj\u00edc\u00ed se, co\u017e \u010din\u00ed tuto kombinaci u\u017eite\u010dnou ve v\u00fdzkumn\u00fdch modelech mnohostrann\u00e9ho poklesu funkce mitochondri\u00ed.<\/p>\n<h3>Zp\u016fsobuje MOTS-c vedlej\u0161\u00ed \u00fa\u010dinky ve v\u00fdzkumu?<\/h3>\n<p>Publikovan\u00fd preklinick\u00fd v\u00fdzkum zaznamenal v\u00fdjime\u010dn\u011b \u010dist\u00fd bezpe\u010dnostn\u00ed profil p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch u hlodavc\u016f, bez konzistentn\u00edch ne\u017e\u00e1douc\u00edch sign\u00e1l\u016f a s dobrou toleranc\u00ed v d\u00e1vkovac\u00edch cyklech trvaj\u00edc\u00edch 4\u201312 t\u00fddn\u016f. MOTS-c je strukturn\u011b endogenn\u00ed lidsk\u00fd peptid, co\u017e sni\u017euje riziko protil\u00e1tkami zprost\u0159edkovan\u00fdch reakc\u00ed pozorovan\u00fdch u upraven\u00fdch analog\u016f. Dlouhodob\u00e9 \u00fadaje o bezpe\u010dnosti u lid\u00ed nejsou k dispozici, proto\u017ee klinick\u00e9 studie jsou st\u00e1le v ran\u00fdch f\u00e1z\u00edch.<\/p>\n<h3>Jak\u00fd je polo\u010das MOTS-c?<\/h3>\n<p>V preklinick\u00e9m v\u00fdzkumu m\u00e1 MOTS-c odhadovan\u00fd plazmatick\u00fd polo\u010das p\u0159ibli\u017en\u011b 3\u20134 hodiny po subkut\u00e1nn\u00edm pod\u00e1n\u00ed. Relativn\u011b kr\u00e1tk\u00fd syst\u00e9mov\u00fd polo\u010das je kompenzov\u00e1n intracelul\u00e1rn\u00ed akumulac\u00ed a rol\u00ed peptidu jako intracelul\u00e1rn\u00ed sign\u00e1ln\u00ed molekuly sp\u00ed\u0161e ne\u017e cirkuluj\u00edc\u00edho hormonu \u2014 \u00fa\u010dinky p\u0159etrv\u00e1vaj\u00ed i po dob\u011b clearance z plazmy ve v\u00fdzkumn\u00fdch modelech.<\/p>\n<h3>Pro\u010d endogenn\u00ed MOTS-c s v\u011bkem kles\u00e1?<\/h3>\n<p>Publikovan\u00e1 kohortov\u00e1 data ukazuj\u00ed p\u0159ibli\u017en\u011b 50% pokles hladin MOTS-c v lidsk\u00e9m s\u00e9ru mezi mlad\u00fdmi a star\u0161\u00edmi dosp\u011bl\u00fdmi. Mechanismus nen\u00ed pln\u011b objasn\u011bn, ale p\u0159edpokl\u00e1d\u00e1 se, \u017ee souvis\u00ed s v\u011bkem spojen\u00fdmi mutacemi mitochondri\u00e1ln\u00ed DNA, poklesem mitochondri\u00e1ln\u00ed transkripce a sn\u00ed\u017eenou biosynt\u00e9zou mitochondri\u00e1ln\u011b k\u00f3dovan\u00fdch peptid\u016f obecn\u011b. V\u011bkem podm\u00edn\u011bn\u00fd pokles je jedn\u00edm z d\u016fvod\u016f, pro\u010d MOTS-c p\u0159itahuje velk\u00fd z\u00e1jem ve v\u00fdzkumu dlouhov\u011bkosti a gerontologie.<\/p>\n<h3>Jak dlouho trv\u00e1, ne\u017e se \u00fa\u010dinky MOTS-c projev\u00ed v preklinick\u00e9m v\u00fdzkumu?<\/h3>\n<p>Akutn\u00ed \u00fa\u010dinky na fosforylaci AMPK a p\u0159\u00edjem gluk\u00f3zy jsou detekovateln\u00e9 ji\u017e b\u011bhem n\u011bkolika hodin po pod\u00e1n\u00ed. \u00da\u010dinky na citlivost na inzul\u00edn a slo\u017een\u00ed t\u011bla u potkan\u016f na vysokotu\u010dn\u00e9 diet\u011b obvykle dos\u00e1hnou statistick\u00e9 v\u00fdznamnosti po 2\u20134 t\u00fddnech pravideln\u00e9ho pod\u00e1v\u00e1n\u00ed. Zlep\u0161en\u00ed v\u00fdkonnosti (vytrvalost na b\u011b\u017e\u00edc\u00edm p\u00e1su, VO2max) se projevuj\u00ed po 4\u20138 t\u00fddnech kontinu\u00e1ln\u00edho pod\u00e1v\u00e1n\u00ed ve v\u00fdzkumu.<sub>2<\/sub>Mohu si objednat MOTS-c s mezin\u00e1rodn\u00ed dopravou?.<\/p>\n<h3>Mohu objednat MOTS-c pro mezin\u00e1rodn\u00ed p\u0159epravu?<\/h3>\n<p>Ano. MedsBase zas\u00edl\u00e1 MOTS-c celosv\u011btov\u011b z na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Objedn\u00e1vky obsahuj\u00edc\u00ed pouze peptidy maj\u00ed n\u00e1rok na na\u0161i samostatnou slu\u017ebu p\u0159epravy peptid\u016f. Ve\u0161ker\u00e9 objedn\u00e1vky zas\u00edl\u00e1me v obalech s kontrolovanou teplotou s pln\u00fdm sledov\u00e1n\u00edm a jsou kryty na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>\u2014 Kardiolipin-v\u00e1zaj\u00edc\u00ed mitochondri\u00e1ln\u00ed tetrapeptid \u2014 kanonick\u00fd stabiliz\u00e1tor vnit\u0159n\u00ed membr\u00e1ny<\/h2>\n<ul>\n<li><a href=\"\/cs\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 Nikotinamidadenindinukleotid \u2014 v\u00fdzkum metabolismu a dlouhov\u011bkosti prost\u0159ednictv\u00edm sirtuinov\u00e9 osy<\/li>\n<li><a href=\"\/cs\/nad\/\"><strong>NAD+<\/strong><\/a> \u2014 Nikotinamidadenindinukleotid \u2014 metabolick\u00fd v\u00fdzkum osy sirtuin\/dlouhov\u011bkost<\/li>\n<li><a href=\"\/cs\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pine\u00e1ln\u00ed tetrapeptid \u2014 v\u00fdzkum aktivace telomer\u00e1zy a dlouhov\u011bkosti<\/li>\n<li><a href=\"\/cs\/semaglutide\/\"><strong>Semaglutide<\/strong><\/a> \u2014 Dlouhodob\u011b p\u016fsob\u00edc\u00ed agonista GLP-1 \u2014 v\u00fdzkum glyk\u00e9mie a t\u011blesn\u00e9 hmotnosti<\/li>\n<li><a href=\"\/cs\/retatrutide\/\"><strong>Retatrutide<\/strong><\/a> \u2014 Trojit\u00fd agonista GLP-1\/GIP\/glukagon \u2014 v\u00fdzkum v\u00edceos\u00e9ho metabolismu<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Porovnejte mitochondri\u00e1ln\u011b c\u00edlen\u00e9 peptidy<\/strong><\/p>\n<p style=\"margin: 0;\">Prozkoumejte \u0161ir\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\"><strong>katalog v\u00fdzkumn\u00fdch peptid\u016f<\/strong><\/a> pro mitochondri\u00e1ln\u00ed a metabolick\u00e9 peptidy v\u010detn\u011b <a href=\"https:\/\/medsbase.com\/cs\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> pro v\u00fdzkum membr\u00e1n c\u00edlen\u00fdch na kardiolipin, <a href=\"https:\/\/medsbase.com\/cs\/nad\/\">NAD+<\/a> pro v\u00fdzkum dlouhov\u011bkosti zam\u011b\u0159en\u00fd na osu sirtuin\u016f a <a href=\"https:\/\/medsbase.com\/cs\/epitalon\/\">Epitalon<\/a> pro v\u00fdzkum dlouhov\u011bkosti zam\u011b\u0159en\u00fd na osu telomer.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Mitochondri\u00e1ln\u011b k\u00f3dovan\u00fd sign\u00e1ln\u00ed peptid<br \/>\n\u2705 Aktivuje metabolickou dr\u00e1hu AMPK<br \/>\n\u2705 Podporuje v\u00fdzkum inzulinov\u00e9 senzitivity<br \/>\n\u2705 Napodobuje \u00fa\u010dinky cvi\u010den\u00ed v preklinick\u00fdch modelech<br \/>\n\u2705 V\u00fdzkumn\u00e1 l\u00e1tka pro dlouhov\u011bkost a gerov\u011bdu<\/p>\n<p><strong>MOTS-c<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70967,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6272,5441],"class_list":{"0":"post-70664","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-mots-c","8":"product_tag-peptide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/70664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=70664"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70967"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=70664"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=70664"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=70664"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=70664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}